E2F1 and ovarian cancer: E2F1 was directly implicated with poor prognosis in types of cancer, such as bladder cancer [7], breast cancer [8], ovarian cancer [9], prostate cancer [4], and has been demonstrated to be a key cancer biomarker [5].